Literature DB >> 21109673

Reprogramming cellular behavior with RNA controllers responsive to endogenous proteins.

Stephanie J Culler1, Kevin G Hoff, Christina D Smolke.   

Abstract

Synthetic genetic devices that interface with native cellular pathways can be used to change natural networks to implement new forms of control and behavior. The engineering of gene networks has been limited by an inability to interface with native components. We describe a class of RNA control devices that overcome these limitations by coupling increased abundance of particular proteins to targeted gene expression events through the regulation of alternative RNA splicing. We engineered RNA devices that detect signaling through the nuclear factor κB and Wnt signaling pathways in human cells and rewire these pathways to produce new behaviors, thereby linking disease markers to noninvasive sensing and reprogrammed cellular fates. Our work provides a genetic platform that can build programmable sensing-actuation devices enabling autonomous control over cellular behavior.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21109673      PMCID: PMC3171693          DOI: 10.1126/science.1192128

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  28 in total

Review 1.  Structure and evolution of transcriptional regulatory networks.

Authors:  M Madan Babu; Nicholas M Luscombe; L Aravind; Mark Gerstein; Sarah A Teichmann
Journal:  Curr Opin Struct Biol       Date:  2004-06       Impact factor: 6.809

2.  Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase.

Authors:  C Tuerk; L Gold
Journal:  Science       Date:  1990-08-03       Impact factor: 47.728

Review 3.  Understanding alternative splicing: towards a cellular code.

Authors:  Arianne J Matlin; Francis Clark; Christopher W J Smith
Journal:  Nat Rev Mol Cell Biol       Date:  2005-05       Impact factor: 94.444

Review 4.  Synthetic RNA circuits.

Authors:  Eric A Davidson; Andrew D Ellington
Journal:  Nat Chem Biol       Date:  2007-01       Impact factor: 15.040

5.  Herpes simplex virus thymidine kinase/ganciclovir-induced apoptosis involves ligand-independent death receptor aggregation and activation of caspases.

Authors:  C Beltinger; S Fulda; T Kammertoens; E Meyer; W Uckert; K M Debatin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

6.  Procaspase-3 enhances the in vitro effect of cytosine deaminase-thymidine kinase disuicide gene therapy on human ovarian cancer.

Authors:  Y Song; B Kong; D Ma; X Qu; S Jiang
Journal:  Int J Gynecol Cancer       Date:  2006 Jan-Feb       Impact factor: 3.437

7.  Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer.

Authors:  Greg M Arndt; Lesley Dossey; Lara M Cullen; Angela Lai; Riki Druker; Michael Eisbacher; Chunyan Zhang; Nham Tran; Hongtao Fan; Kathy Retzlaff; Anton Bittner; Mitch Raponi
Journal:  BMC Cancer       Date:  2009-10-20       Impact factor: 4.430

8.  Reprogramming alternative pre-messenger RNA splicing through the use of protein-binding antisense oligonucleotides.

Authors:  Jonathan Villemaire; Isabelle Dion; Sherif Abou Elela; Benoit Chabot
Journal:  J Biol Chem       Date:  2003-09-30       Impact factor: 5.157

9.  H1 RNA polymerase III promoter-driven expression of an RNA aptamer leads to high-level inhibition of intracellular protein activity.

Authors:  Jing Mi; Xiuwu Zhang; Zahid N Rabbani; Yingmiao Liu; Zhen Su; Zeljko Vujaskovic; Christopher D Kontos; Bruce A Sullenger; Bryan M Clary
Journal:  Nucleic Acids Res       Date:  2006-07-19       Impact factor: 16.971

10.  Co-expression of anti-NFkappaB RNA aptamers and siRNAs leads to maximal suppression of NFkappaB activity in mammalian cells.

Authors:  Robert Chan; Madaline Gilbert; Kristin M Thompson; H Nicholas Marsh; David M Epstein; P Shannon Pendergrast
Journal:  Nucleic Acids Res       Date:  2006-03-03       Impact factor: 16.971

View more
  115 in total

1.  Synthetic biology: Automated design of RNA devices.

Authors:  Farren J Isaacs
Journal:  Nat Chem Biol       Date:  2012-04-17       Impact factor: 15.040

2.  Rationally designed families of orthogonal RNA regulators of translation.

Authors:  Vivek K Mutalik; Lei Qi; Joao C Guimaraes; Julius B Lucks; Adam P Arkin
Journal:  Nat Chem Biol       Date:  2012-03-25       Impact factor: 15.040

3.  Programmable single-cell mammalian biocomputers.

Authors:  Simon Ausländer; David Ausländer; Marius Müller; Markus Wieland; Martin Fussenegger
Journal:  Nature       Date:  2012-07-05       Impact factor: 49.962

4.  Cell signalling: RNA device rewires cellular networks.

Authors:  Tanita Casci
Journal:  Nat Rev Mol Cell Biol       Date:  2010-12-08       Impact factor: 94.444

5.  RNA device rewires cellular networks.

Authors:  Tanita Casci
Journal:  Nat Rev Genet       Date:  2010-12-07       Impact factor: 53.242

6.  Therapeutics: RNA device rewires cellular networks.

Authors:  Tanita Casci
Journal:  Nat Rev Cancer       Date:  2011-01       Impact factor: 60.716

Review 7.  Synthetic RNA switches as a tool for temporal and spatial control over gene expression.

Authors:  Andrew L Chang; Joshua J Wolf; Christina D Smolke
Journal:  Curr Opin Biotechnol       Date:  2012-02-03       Impact factor: 9.740

Review 8.  Recent advances and versatility of MAGE towards industrial applications.

Authors:  Vijai Singh; Darren Braddick
Journal:  Syst Synth Biol       Date:  2015-11-07

Review 9.  Foundations for the design and implementation of synthetic genetic circuits.

Authors:  Adrian L Slusarczyk; Allen Lin; Ron Weiss
Journal:  Nat Rev Genet       Date:  2012-05-18       Impact factor: 53.242

Review 10.  Synthetic biology in mammalian cells: next generation research tools and therapeutics.

Authors:  Florian Lienert; Jason J Lohmueller; Abhishek Garg; Pamela A Silver
Journal:  Nat Rev Mol Cell Biol       Date:  2014-01-17       Impact factor: 94.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.